Envoy Medical, Inc. (COCH) Revenue History
Annual and quarterly revenue from 2021 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
COCH Revenue Growth
Revenue Breakdown (FY 2025)
COCH's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
COCH Revenue Analysis (2021–2025)
As of May 8, 2026, Envoy Medical, Inc. (COCH) generated trailing twelve-month (TTM) revenue of $241,000, reflecting explosive growth of +78.6% year-over-year. The most recent quarter (Q4 2025) recorded $75,000 in revenue, up 78.6% sequentially.
Looking at the longer-term picture, COCH's historical revenue data shows a 3-year CAGR of +0.6%. The company achieved its highest annual revenue of $316,000 in 2023.
Revenue diversification analysis shows COCH's business is primarily driven by Other Operating Segment (100%). With over half of revenue concentrated in Other Operating Segment, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including LNTH (+0.6% YoY), MDT (+6.9% YoY), and ABT (+6.4% YoY), COCH has outperformed the peer group in terms of revenue growth. Compare COCH vs LNTH →
COCH Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| COCHCurrent | $241,000 | +78.6% | - | -9240.7% | |
 LNTH | $1.5B | +0.6% | +35.3% | 20.2% | |
 MDT | $33.5B | +6.9% | +3.0% | 17.8% | |
 ABT | $42.0B | +6.4% | +5.6% | 16.3% | |
 BSX | $20.1B | +19.9% | +15.2% | 19.8% | |
 WST | $3.1B | +11.2% | +7.4% | 20.1% |
COCH Historical Revenue Data (2021–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $241K | +7.1% | $-633,000 | -262.7% | $-22,270,000 | -9240.7% |
| 2024 | $225K | -28.8% | $-517,000 | -229.8% | $-19,256,000 | -8558.2% |
| 2023 | $316K | +33.3% | $-473,000 | -149.7% | $-18,359,000 | -5809.8% |
| 2022 | $237K | -23.5% | $-261,000 | -110.1% | $-8,706,000 | -3673.4% |
| 2021 | $310K | - | $-459,000 | -148.1% | $-6,871,000 | -2216.5% |
See COCH's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs COCH Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare COCH vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonCOCH — Frequently Asked Questions
Quick answers to the most common questions about buying COCH stock.
Is COCH's revenue growth accelerating or slowing?
COCH revenue is accelerating at +78.6% year-over-year, exceeding the 5-year CAGR of N/A. TTM revenue reached $241000.00. Growth momentum has increased versus prior periods.
What is COCH's long-term revenue growth rate?
Envoy Medical, Inc.'s 5-year revenue CAGR of N/A reflects the sustained expansion pattern. Current YoY growth of +78.6% is above this long-term average.
How is COCH's revenue distributed by segment?
COCH reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2021-2025 are available for download. Segment mix reveals concentration and diversification trends.